Perfil
Sonia Gulati is currently the Chief Executive Officer & Director at Leukovet.
She is also a Director at TigaTx, Inc. and an Investment Review Committee Member at Accelerate Long Island (Venture Capital).
Previously, she was a Director at Actinobac Biomed, Inc., Pinpoint Therapeutics, Inc., and 1200 Pharma LLC.
She was also an Assistant Director at New York Ventures.
Dr. Gulati received her undergraduate degree from Barnard College and her doctorate from Columbia University School of the Arts in 2011.
Cargos activos de Sonia Gulati
| Empresas | Cargo | Inicio |
|---|---|---|
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Develops peptide-based cancer therapeutics for treatment of canine lymphoma, leukemia and other immunological diseases | Director Ejecutivo | - |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed stage capital requirements. The firm makes follow-on investments. | Inversor de Capital Privado | - |
TigaTx, Inc.
TigaTx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops engineered immunoglobulin to create isotype cancer antibody | Director/Miembro de la Junta | 01/09/2009 |
Antiguos cargos conocidos de Sonia Gulati.
| Empresas | Cargo | Fin |
|---|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technologies | Director/Miembro de la Junta | 30/09/2021 |
1200 Pharma LLC
1200 Pharma LLC Pharmaceuticals: MajorHealth Technology Provides pre-clinical drug discovery and clinical approval services | Director/Miembro de la Junta | 31/08/2021 |
Pinpoint Therapeutics, Inc.
Pinpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for cancer treatments | Director/Miembro de la Junta | 31/08/2021 |
New York Ventures
New York Ventures Investment ManagersFinance New York State Innovation invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in seed and early-stage transactions. | Inversor de Capital Privado | 31/12/2018 |
Formación de Sonia Gulati.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Barnard College
Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technologies | Health Technology |
New York Ventures
New York Ventures Investment ManagersFinance New York State Innovation invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in seed and early-stage transactions. | Finance |
Columbia University School of the Arts
Columbia University School of the Arts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
1200 Pharma LLC
1200 Pharma LLC Pharmaceuticals: MajorHealth Technology Provides pre-clinical drug discovery and clinical approval services | Health Technology |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed stage capital requirements. The firm makes follow-on investments. | Finance |
Pinpoint Therapeutics, Inc.
Pinpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for cancer treatments | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Develops peptide-based cancer therapeutics for treatment of canine lymphoma, leukemia and other immunological diseases | Health Technology |
TigaTx, Inc.
TigaTx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops engineered immunoglobulin to create isotype cancer antibody | Health Technology |
- Bolsa de valores
- Insiders
- Sonia Gulati
















